Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Microorganisms|November 25, 2023
Analysis of Mould Exposure of Immunosuppressed Patients at a German University HospitalDanuta Puhlmann, Dominic Bergmann, Silke Besier, et al.
American Journal of Infection Control|September 23, 2020
A quality improvement study on the reduction of central venous catheter-associated bloodstream infections by use of self-disinfecting venous access caps (STERILE)Rebeca Cruz-Aguilar, Jonathan Carney, Vanessa Mondaini, et al.
BMC Pulmonary Medicine|June 17, 2026
Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) studyCarla Bellinghausen, Achim Grünewaldt, Tara Azem, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxisLena M Biehl, J Janne Vehreschild, Blasius Liss, et al.
European Journal of Neurology|January 18, 2023
The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathyMartin K R Svačina, Alina Sprenger-Svačina, Anastasia Tsakmaklis, et al.
Frontiers in Immunology|February 26, 2019
Compartmentalization of Immune Response and Microbial Translocation in Decompensated CirrhosisCamila Alvarez-Silva, Robert Schierwagen, Alessandra Pohlmann, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosisGudrun Würthwein, Oliver A Cornely, Mirjam N Trame, et al.
Infection|May 28, 2026
vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective studySebastian Wolf, Nico Zeltner, Nele Henze, et al.
Mycoses|February 3, 2017
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope RegistryLuisa Durán Graeff, Danila Seidel, Maria J G T Vehreschild, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2022
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolonesMaria J G T Vehreschild, Annie Ducher, Thomas Louie, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Microorganisms|November 25, 2023
Analysis of Mould Exposure of Immunosuppressed Patients at a German University HospitalDanuta Puhlmann, Dominic Bergmann, Silke Besier, et al.
American Journal of Infection Control|September 23, 2020
A quality improvement study on the reduction of central venous catheter-associated bloodstream infections by use of self-disinfecting venous access caps (STERILE)Rebeca Cruz-Aguilar, Jonathan Carney, Vanessa Mondaini, et al.
BMC Pulmonary Medicine|June 17, 2026
Symptom burden, lung function, exercise tolerance and inflammation in patients post COVID-19: results from the prospective COVID-19 Chronic Morbidity (CCHROMO) studyCarla Bellinghausen, Achim Grünewaldt, Tara Azem, et al.
The Journal of Antimicrobial Chemotherapy|June 19, 2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxisLena M Biehl, J Janne Vehreschild, Blasius Liss, et al.
European Journal of Neurology|January 18, 2023
The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathyMartin K R Svačina, Alina Sprenger-Svačina, Anastasia Tsakmaklis, et al.
Frontiers in Immunology|February 26, 2019
Compartmentalization of Immune Response and Microbial Translocation in Decompensated CirrhosisCamila Alvarez-Silva, Robert Schierwagen, Alessandra Pohlmann, et al.
Antimicrobial Agents and Chemotherapy|January 22, 2013
Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosisGudrun Würthwein, Oliver A Cornely, Mirjam N Trame, et al.
Infection|May 28, 2026
vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective studySebastian Wolf, Nico Zeltner, Nele Henze, et al.
Mycoses|February 3, 2017
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope RegistryLuisa Durán Graeff, Danila Seidel, Maria J G T Vehreschild, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2022
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolonesMaria J G T Vehreschild, Annie Ducher, Thomas Louie, et al.
Pageof 23